Helper virus-free transfer of human immunodeficiency virus type 1 vectors
|
|
- Lynne Manning
- 6 years ago
- Views:
Transcription
1 Journal of General Virology (1995), 76, Printed in Great Britabz 691 Helper virus-free transfer of human immunodeficiency virus type 1 vectors Jennifer H. Riehardson,~ Jane F. Kaye, Lisa A. Child and Andrew M. L. Lever* University of Cambridge Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK Recombinant vectors based on the type 1 human immunodeficiency virus (HIV-1) can be used to deliver genes into cells expressing the HIV receptor, CD4. We have used a transient RNA packaging system to compare the safety and efficacy of HIV-1 vector transduction by wild-type and replication-deficient helper viruses. Helper virus-free vector transfer was consistently achieved when the helper virus gag-pol and env genes were expressed from separate plasmids such that two recombination events were required to form an infectious genome. Other forms of attenuation, such as deletion of the 5' W region, were inadequate to prevent helper virus transmission. Vector transduction by the wild-type and non-replicating helper viruses occurred with comparable efficiency except in instances where efficient vector RNA expression was dependent upon transactivating factors supplied by the helper virus. These data demonstrate the feasibility of safe gene transfer using HIV-1 vectors. Retrovirus vectors currently offer the most efficient means of stable gene transfer into vertebrate cells. Recombinant vectors based on human immunodeficiency virus type 1 (HIV-1) provide in addition a means of targeting foreign genes to cells expressing CD4, the HIV receptor, and could be used to deliver genes with therapeutic or antiviral potential into primary human T cells. Vectors based on HIV-1 may have other advantages over murine retroviral vectors, such as the ability to infect non-dividing cells (Weinberg et al., 1991 ; Lewis et al., 1992) and the potential for using the HIV-1 regulatory genes tat and rev to achieve inducible expression of the vector RNA. One factor currently limiting the utility of HIV-1 vectors is the absence of an efficient system for vector packaging. In this paper we examine aspects of helper virus design that will contribute to the design of a safe and effective packaging system. Retroviral vectors, in which some or all of the viral genes are replaced by foreign sequences, require a separate helper virus in order to be packaged and transferred to the target cell. To avoid transmission of the helper virus itself, vector systems based on murine and avian retroviruses have used helper viruses which have a cis-acting replication defect such as deletion of the RNA packaging signal (termed q~ or E). This cis-acting element allows selective encapsidation of the viral genomic RNA. In all retroviruses studied, an essential * Author for correspondence. Fax t Present address: Division of Human Retrovirology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. component of the RNA packaging signal is located at the 5' end of the genome, often encompassing or downstream of the major splice donor (Linial & Miller, 1990; Richardson et al., 1993 and references therein). Cell lines stably transfected with the mutant proviruses have been termed packaging cell lines and produce virion particles devoid of the ~- helper virus genome but capable of encapsidating a ud+ vector RNA. In practice, removal of the packaging signal has proved insufficient to prevent helper virus transmission because of low-level encapsidation of the W- genome and recombination between the helper virus and vector RNAs. In the more recent packaging lines based on Moloney murine leukaemia virus (M-MuLV), reticuloendotheliosis virus (REV) and avian leukosis virus (ALV), the scope for helper virus transfer has been substantially reduced by replacement of the helper virus long terminal repeat (LTR) sequences with alternative promoter or polyadenylation signals and/or by the physical separation of gag-pol and env genes (Miller, 1990; Dougherty et al., 1989; Cosset et al., 1990). These modifications increase the number of recombination events required to generate an infectious genome. We recently described a series of HIV-1 vectors and identified several that could be packaged and transduced with high efficiency by a replication-competent (wild-type) helper virus. In this paper we show that helper virus-free transfer of such vectors can be achieved using strategies similar to those employed in murine and avian retrovirus packaging cell lines. A transient packaging system was used to compare the transducing capability and infectivity of wild-type HIV- 1 and a series of replication-deficient helper viruses. 5 to SGM
2 692 Short communication (a) HVP ]J fl ~ 6.4 kb gag [pr0 }..v I pu.o A A LGRPL IN gag [ env ]PURO 4-5 kb (b) g.g I.o, env m (i) HXBc2 TGGTGAGTACGCCAAAAATTTFGACTAGCGGAGGCTAGAAGGAGAGAGATG A (ii) HXB,~P1 (iii) phxbap2 TGGTGAGTACGCC A TGGTGAGTACT~ A -GGCTAGAAGGAGAGAGATG GAGATG (iv) phxbap1altr ~ ga~ [ pol env (v) phxbapi~env ~ gag [ pol ~ env + + plenv [-~'--F'" env k'1 Fig. 1. (a) HIV-1 vectors. Hatched and filled boxes represent exons of tat and rev respectively. The underlined area within env represents the Rev-responsive element. Relevant splice donor (~) and splice acceptor (A) sites are indicated. (b) Helper virus constructs used for packaging. 10 lag each of vector and packaging plasmids (Fig. 1) were cotransfected into COS-1 cells using the DEAEdextran technique (Selden, 1987). All of the plasmids contain a simian virus 40 (SV40) origin of replication. Virus-containing supernatants were harvested 72 h later and used immediately to infect CD4-positive or -negative cells. A colony-forming assay was used to estimate the efficiency of vector transduction by the various helper virus plasmids (Richardson et al., 1993). Briefly, 0.45 lamfiltered vector stocks were inoculated onto HeLa cells expressing human CD4 or CD8 and the number of puromycin-resistant colonies was scored 10 to 12 days later. Vector stocks were also used to infect the CD4- positive cell line Jurkat tat (Rosen et al., 1986). Puromycin selection was applied 24 h later at 0.5 lag/ml and cells containing the transduced vector were cultured for molecular and virological analysis. The helper virus constructs used were (i) phxbc2, a fully infectious molecular clone of HIV-1 ; (ii) phxbap 1, a previously described mutant of phxbc2 which has a 19 bp deletion between the major splice donor and gag initiation codon, resulting in impaired viral replication (Lever et al., 1989); (iii) phxbap2, which has a 36 bp deletion between the splice donor and gag initiation codon (this deletion results in a more severe replication defect); (iv) phxbapialtr, a non-infectious derivative of phxbap1 which was obtained by deleting sequences downstream of the XhoI site (8897) (this removes the entire 3" LTR without affecting viral protein synthesis; the polyadenylation site used in this construct
3 Short communication 693 Table 1. Vector transduction efficiency by different helper virus constructs Puro R (c.f.u./ml)* HeLaT4 Helper Secondary Packaging HeLaT8 virus vector Vector plasmid/s) TCIDs0 ~" transfer HVP HXBc HVP HXBAP ND HVP HXBAP ND ND HVP HXBAP1AYLTR < 10 + HVP Dual plasmid LGRPL HXBc2 0 ND ND + LGRPL Dual plasmid 0 ND ND -- * Normalized for a typical reverse transcriptase activity of 106 c.p.m./ml. f Infectious virus titre expressed as syncytium-forming units/ml of COS supernatant; normalized for reverse transcriptase activity of 106 c.p.m./ml: mean of four experiments. ND, Not done. has not been determined); (v) phxbap1aenv, a noninfectious mutant ofphxbap1 lacking a BglII fragment ( ) in the env gene. The env-deleted provirus required a complementary envelope-expressing plasmid to produce intact virion particles and we refer to this below as a 'dual plasmid' helper virus system. Table 1 summarizes the vector transfer results. The HVP vector, a tat- and rev-positive vector that also contains gag protease and env sequences (Richardson et al., 1993) was transduced with moderate efficiency by all of the helper virus constructs. There was no significant difference between the transduction titres obtained using the wild-type, ul-, and LTR viruses. A small but reproducible decrease in titre was seen when the dual plasmid helper system was used. No colonies were obtained when HeLa cells expressing the CD8 molecule were used for infection, clearly demonstrating the CD4- specificity of the transducing virus. The actual titres were somewhat variable between experiments, suggesting that the COS cell system is rather sensitive to minor variations in experimental conditions. LGRPL is a Tat and Rev-inducible vector, containing gag and env sequences but lacking Tat and Rev functions. Using the wild-type HXBc2 helper virus, the LGRPL vector gave ~ fourfold fewer colonies than HVP. We have shown elsewhere that both vectors are efficiently encapsidated (Richardson et al., 1993) and the lower titre may reflect differences in transfection efficiency or expression of the two vector plasmids. Transduction of the LGRPL vector was consistently reduced by a factor of about ten when the dual plasmid helper system was used. The selectable marker (puro gene in LGRPL) is expressed using the 5' LTR promoter and is sensitive to transactivation by the HIV-1 Tat protein. Infection of the target cells by helper virus may therefore improve the colony-forming ability of this vector by Tat-mediated transactivation of the vector LTR. To compare the infectivity of the wild-type and replication-deficient helper viruses, titres of infectious virus in the COS cell supernatants were measured using a TCIDs0 assay (Johnson & Byington, 1990). Briefly, Jurkat tat cells were infected with serial fourfold dilutions of virus (six replicates at each dilution) and wells were scored for the presence of syncytia 7 to 10 days later. The results in Table 1 clearly demonstrate the reduced infectivity of the mutant proviruses HXBAP1 and HXBAP2 but also indicate that this level of attenuation is not sufficient to prevent helper virus transmission. Infectious virus was also recovered on one of three occasions when the HVP vector was cotransfected with the non-infectious provirus HXBAP 1ALTR, which lacks a 3' LTR. This was not unexpected as a single recombination event between the vector and helper virus would generate an infectious genome. Infectious virus was reduced to undetectable levels by expressing Gag-Pol and Env proteins from separate plasmids so that two recombination events were required to generate an infectious genome. Further data on helper virus transmission was obtained by monitoring the target cell cultures for evidence of infection. These were assayed for HIV-1 cytopathic effects (syncytium formation) and reverse transcriptase activity over a 4 to 6 week period (Ports, 1990). RNA isolated from the cells was also screened for the presence of helper virus RNA by Northern blot analysis and cellfree culture supernatant from the transduced cells was inoculated onto fresh Jurkat tat cells to test for horizontal (or secondary) transfer of the vector. The wild-type helper virus was invariably transmitted to target cell cultures, as determined by all of the above criteria (Table 1 and Fig. 2). In contrast, ceils transduced using the dual plasmid packaging system showed no evidence of reverse transcriptase activity or cytopathic effect during a 6 week monitoring period. Moreover, supernatants from these
4 694 Short communication (a) 2~ (c) "d a:,.~,...a,..a,..a,-...1,-.1,..a 1 28S s S 18S 1 (b) 2 3 ~ gag ~a~ gag l pol 533 I 6 7 1~ env I PURO HVP LGRPL 1~ 4 ]pro -~ ~ env ~ XI~1 N env I PURO ~ HXBC2 357 Fig. 2. (a) Northern blot analysis of cells transduced with the HVP vector. Filters were hybridized with puro gene (upper panel) or pol gene (lower panel) probes. Each lane represents a separate experiment and the helper virus used for transduction is indicated above each lane. (b) Diagram showing the expected SacI restriction fragments of the HXBc2 provirus, HVP and LGRPL. Recombination in the region shown would explain the R band. (c) Southern blot analysis of Jurkat tat cells following stable transfection or transduction of the HVP and LGRPL vectors. Genomic DNA digested with SacI was probed with a SacI fragment of LGRPL. Lane 1, cells transfected with HVP; lanes 2 and 3, cells transduced with HVP using wild-type (HXBc2) and dual plasmid helper virus systems; lane 4, HTLVIII~-infected cells; lane 5, cells transfected with LGRPL; lanes 6 and 7: cells transduced with LGRPL using wild-type (HXBc2) and dual plasmid helper systems. R indicates a putative recombination product described in the text.
5 Short communication 695 cultures failed to transmit puromycin resistance to fresh Jurkat tat cells, consistent with the absence of packaging functions in the cells. A cumulative total of ~ 30 ml of dual plasmid-derived vector stock was screened in this way for replication-competent virus and none was detected. Northern blot analysis confirmed the presence of the intact vector RNA in the target cells and showed no evidence of helper virus infection in 4/4 independent experiments when the dual plasmid packaging system was used (Fig. 2a). Total RNA was extracted from the cells and hybridized with puro and pol gene probes as previously described (Richardson et al., 1993). The puro probe revealed the expected HVP vector transcripts of approximately 6.1, 4.2, and 2.1 kb (and a minor 1"7 kb species, probably arising from a cryptic 3' splice site). Using a helper virus-specific probe (pol fragment ), full-length (9 kb) helper virus RNA could be demonstrated in target cells when the wild-type (HXBc2) virus was used for transduction but was not detectable when vector transduction was achieved using the dual plasmid helper system. Southern blot analysis was used to confirm the presence of intact vector in target cell cultures. Using a SacI fragment of LGRPL to probe SacI-digested genomic DNA, fragments of the expected sizes for HVP (2.20 kb and 3"50 kb) and LGRPL (3.88 kb) were seen. Bands of 3'57 kb and 5'33 kb corresponding to the helper provirus can be seen when infectious helper virus was used but not after transfer using the dual plasmid helper system (Fig. 2). Where both infectious virus and vector are present, an additional fragment labelled R in Fig. 2(c) can be seen. From its length (~ 4 kb) we postulate that this fragment is the result of recombination between the vector and helper virus which would produce an extended env +puro fragment of 4.08 kb. Cellular RNA prepared at the same time as the DNA showed little evidence of such a recombination (Fig. 2), but this may relate to the kinetics of formation or expression of the recombinant provirus. The development of HIV- 1-based vectors as a safe and effective means of gene delivery carries the dual advantages that genes can be targeted to CD4-positive cells and that, subsequently, vector gene expression can be induced by viral trans-activators such as the Tat and Rev proteins. We have shown here that helper virus-free transmission of HIV-1-based vectors is both feasible and CD4-specific. Helper virus-free vector transfer was routinely achieved when the helper virus gag-pol and env genes were expressed from separate plasmids such that two recombination events were required to form an infectious genome. Other forms of attenuation such as deletion of the 5' W region were inadequate to prevent helper virus transmission as the W-deleted genomes were encapsi- dated to a low extent. Infectious virus was also recovered in circumstances where a single recombination event between a defective helper virus and the vector RNA could generate an infectious genome. The vector titres obtained using this transient packaging system were considerably lower than those obtained when the same vectors are packaged by a wildtype helper virus in T cell lines (Richardson et al., 1993). This partly reflects the lower concentration of virus particles in the COS cell supernatant, but even after normalizing for reverse transcriptase activity, transduction titres were ~ 10-fold lower using the COS cell system. Other groups have reported similar low titres when using COS-1 cells for HIV-1 vector packaging, suggesting that this is not an optimal cell type for the assembly of HIV-1 vectors (Hayashi et al., 1992; Shimada et al., 1991; Buchschacher & Panganiban, 1992). With the development of stable packaging cell lines capable of producing high titres of helper virus-free vector, HIV-1 vectors should ultimately prove a safe and effective tool for the genetic manipulation of CD4- expressing cells. The system may find wide application in molecular immunology and has clear potential for a genetic approach to the treatment of HIV infection. We thank Dr J. Sodroski for a number of plasmids used in this study and Charles Wright for technical assistance. This work was supported by the Medical Research Council (UK) AIDS Directed Programme, NATO and the Sykes Trust. References BUCHSCHACHER, G. L. & PANGANIBAN, A. T. (1992). Human immunodeficiency virus vectors for inducible expression of foreign genes. Journal of Virology 66, COSSET, F. L., LEGRAS, C., CHEBLOUNE, Y., SAVATIER, P., THORAVAL, P., THOMAS, J. L., SAMARUT, J.~ NIGON, V. M. VERDIER, G. (1990). A new avian leukosis virus-based packaging cell line that uses two separate transcomplementing helper genomes. Journal of Virology 64, DOUGHERTY, J. P., WISNIEWSKI, R., YANG, S., RHODE, B. W. & TEMIN, H. W. (1989). New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. Journal of Virology 63, HAYASHIL T., SHIODA, T., IWAKURA, Y. & SEIIBUTA, H. (1992). RNA packaging signal of human immunodeficiency virus type 1. Virology 188, JOHNSON, V.A. & BYINGTON, R.E. (1990). Quantitative assays for virus infectivity. In Techniques in HIV Research, pp Edited by A. Aldovini & B. D. Walker. New York: Stockton Press. LEVER, A. M. L., GOTTLINGER, H., HASELTINE, W. & SODROSKI, J. (1989). Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. Journal of Virology 63, LEWIS, P., HENSEL, M. & EMERMAN, M. (1992). Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO Journal 11, LINIAL, M. & MILLER, A. D. (1990). RNA Packaging. In Retroviruses: Strategies of Replication, pp Edited by R. Swanstrom & P. K. Vogt. Berlin: Springer-Verlag. MILLER, A. D. (1990). Retrovirus packaging cells. Human Gene Therapy 1, 5-14.
6 696 Short communication POTTS, B.J. (1990). ~Mini' reverse transcriptase (RT) assay. In Techniques in H1V Research, pp Edited by A. Aldovini & B. D. Walker. New York: Stockton Press. RICHARDSON, J. H, CHILD, L. A. & LEVER, A. M. L. (1993). Packaging of human immunodeficiency virus type 1 RNA requires c/s-acting sequences outside the 5' leader region. Journal of Virology 67, ROSEN, C.A., SODROSKI, J.G., CAMPBELL, K, & HASELTtNE, W.A. (1986). Construction of recombinant routine retroviruses that express the human T-cell leukemia virus type III trans-activator genes. Journal of Virology 57, SELDEN, R. F. (1987). Transfection using DEAE-dextran. In Current Protocols in Molecular Biology, vol. t, unit 9.2. Edited by R. Ausubel, R. E. Brent, D. D. Kingston, J. G. Moore, J. A. Seidman, J. A. Smith & K. Struhl. New York: Wiley Interscience. SHIMADA, T., FUJtl, H., MITSUYA, H. & NIENHUIS, A.W. (1991). Targeted and highly efficient gene transfer into CD4 + cells by a recombinant human immunodeficiency virus retroviral vector. Journal of Clinical Investigation 88, WEINBERG, J. B., MATTHWEWS, T. J., CULLEN, B. R. & MALIM, M. H. (1991). Productive human immunodeficiency virus type 1 (HIV-1) infection of non proliferating human monocytes. Journal of Experimental Medicine 174, (Received 11 July 1994; Accepted 24 October 1994)
Development of cell lines stably expressing human immunodeficiency virus type 1 proteins for studies in encapsidation and gene transfer
Journal of General Virology (1998), 79, 231 237. Printed in Great Britain...... Development of cell lines stably expressing human immunodeficiency virus type 1 proteins for studies in encapsidation and
More informationVIROLOGY. Engineering Viral Genomes: Retrovirus Vectors
VIROLOGY Engineering Viral Genomes: Retrovirus Vectors Viral vectors Retrovirus replicative cycle Most mammalian retroviruses use trna PRO, trna Lys3, trna Lys1,2 The partially unfolded trna is annealed
More informationPackaging and Abnormal Particle Morphology
JOURNAL OF VIROLOGY, OCt. 1990, p. 5230-5234 0022-538X/90/105230-05$02.00/0 Copyright 1990, American Society for Microbiology Vol. 64, No. 10 A Mutant of Human Immunodeficiency Virus with Reduced RNA Packaging
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 RETROVIRUSES. 2. HTLV-II causes hairy T-cell leukemia
1 of 7 I. Diseases Caused by Retroviruses RETROVIRUSES A. Human retroviruses that cause cancers 1. HTLV-I causes adult T-cell leukemia and tropical spastic paraparesis 2. HTLV-II causes hairy T-cell leukemia
More informationIntroduction. DR Chadwick and AML Lever Department of Medicine, University of Cambridge, Addenbrooke s Hospital, Cambridge CB2 2QQ, UK
(2000) 7, 1362 1368 2000 Macmillan Publishers Ltd All rights reserved 0969-7128/00 $15.00 www.nature.com/gt ACQUIRED DISEASES RESEARCH ARTICLE Antisense RNA sequences targeting the 5 leader packaging signal
More informationFayth K. Yoshimura, Ph.D. September 7, of 7 HIV - BASIC PROPERTIES
1 of 7 I. Viral Origin. A. Retrovirus - animal lentiviruses. HIV - BASIC PROPERTIES 1. HIV is a member of the Retrovirus family and more specifically it is a member of the Lentivirus genus of this family.
More informationFrequent Segregation of More-Defective Variants from a Rous Sarcoma Virus Packaging Mutant, TK15
JOURNAL OF VIROLOGY, Oct. 1987, p. 3208-3213 0022-538X/87/103208-06$02.00/0 Copyright 1987, American Society for Microbiology Vol. 61, No. 10 Frequent Segregation of More-Defective Variants from a Rous
More informationRecombinant Protein Expression Retroviral system
Recombinant Protein Expression Retroviral system Viruses Contains genome DNA or RNA Genome encased in a protein coat or capsid. Some viruses have membrane covering protein coat enveloped virus Ø Essential
More informationRetroviruses. ---The name retrovirus comes from the enzyme, reverse transcriptase.
Retroviruses ---The name retrovirus comes from the enzyme, reverse transcriptase. ---Reverse transcriptase (RT) converts the RNA genome present in the virus particle into DNA. ---RT discovered in 1970.
More informationGenetic consequences of packaging two RNA genomes in one retroviral particle: Pseudodiploidy and high rate of genetic recombination
Proc. Natl. Acad. Sci. USA Vol. 87, pp. 1556-1560, February 1990 Microbiology Genetic consequences of packaging two RNA genomes in one retroviral particle: Pseudodiploidy and high rate of genetic recombination
More informationViral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP
Viral Vectors In The Research Laboratory: Just How Safe Are They? Dawn P. Wooley, Ph.D., SM(NRM), RBP, CBSP 1 Learning Objectives Recognize hazards associated with viral vectors in research and animal
More informationVIRUSES AND CANCER Michael Lea
VIRUSES AND CANCER 2010 Michael Lea VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses HISTORICAL REVIEW Historical Review
More information~Lentivirus production~
~Lentivirus production~ May 30, 2008 RNAi core R&D group member Lentivirus Production Session Lentivirus!!! Is it health threatening to lab technician? What s so good about this RNAi library? How to produce
More informationSupplementary Information. Supplementary Figure 1
Supplementary Information Supplementary Figure 1 1 Supplementary Figure 1. Functional assay of the hcas9-2a-mcherry construct (a) Gene correction of a mutant EGFP reporter cell line mediated by hcas9 or
More informationCURRENT DEVELOMENTS AND FUTURE PROSPECTS FOR HIV GENE THERAPY USING INTERFERING RNA-BASED STRATEGIES
[Frontiers in Bioscience 5, d527-555, May 1, 2000] CURRENT DEVELOMENTS AND FUTURE PROSPECTS FOR HIV GENE THERAPY USING INTERFERING RNA-BASED STRATEGIES Betty Lamothe, Sadhna Joshi Department of Medical
More informationSupplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR
Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4
More informationDATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA.
Viral Load DNA >> Standard PCR standard 0 Copies Catalog Number: 1122 Lot Number: 150298 Release Category: A Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter
More informationCDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm
More informationQin Yu and Casey D. Morrow 1. Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama 35294
Virology 254, 160 168 (1999) Article ID viro.1998.9542, available online at http://www.idealibrary.com on Complementarity between 3 Terminal Nucleotides of trna and Primer Binding Site Is a Major Determinant
More information7.012 Quiz 3 Answers
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84
More informationActivation of Gene Expression by Human Herpes Virus 6
Activation of Gene Expression by Human Herpes Virus 6 M. E. M. Campbell and S. McCorkindale 1 Introduction Human herpes virus type 6 (HHV-6) was first detected by Salahuddin et al. [6] and has been isolated
More informationEven Transcriptionally Competent Proviruses Are Silent in Bovine Leukemia Virus Induced Tumor Cells*
Even Transcriptionally Competent Proviruses Are Silent in Bovine Leukemia Virus Induced Tumor Cells* A. van den Broeke 1, Y. Cleuter 2, G. Chen 3, D. Portetelle 3, M. Mammerickx\ D. Zagury5, M. Fouchard
More informationNBP Protocol. Orders: Support: Web: NBP
NBP2-29541 NBP2-29541 Protocol Orders: orders@novusbio.com Support: technical@novusbio.com Web: www.novusbio.com Protocols, Publications, Related Products, Reviews and more: www.novusbio.com/nbp2-29541
More informationIntroduction retroposon
17.1 - Introduction A retrovirus is an RNA virus able to convert its sequence into DNA by reverse transcription A retroposon (retrotransposon) is a transposon that mobilizes via an RNA form; the DNA element
More informationThis training module is required for all personnel listed on an IBC protocol that describes work utilizing viral vectors (both replication competent
This training module is required for all personnel listed on an IBC protocol that describes work utilizing viral vectors (both replication competent and incompetent) regardless of the biosafety level used
More informationSupplementary information. MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins
Supplementary information inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins Takuya Tada, Yanzhao Zhang, Takayoshi Koyama, Minoru Tobiume, Yasuko Tsunetsugu-Yokota, Shoji
More informationFeb 11, Gene Therapy. Sam K.P. Kung Immunology Rm 417 Apotex Center
Gene Therapy Sam K.P. Kung Immunology Rm 417 Apotex Center Objectives: The concept of gene therapy, and an introduction of some of the currently used gene therapy vector Undesirable immune responses to
More informationHIV INFECTION: An Overview
HIV INFECTION: An Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL MBBS II SEMINAR VJ
More informationRole of the C terminus Gag protein in human immunodefieieney virus type 1 virion assembly and maturation
Journal of General Virology (1995), 76, 3171-3179. Printed in Great Britain 3171 Role of the C terminus Gag protein in human immunodefieieney virus type 1 virion assembly and maturation X.-F. Yu, ~ Z.
More informationVarying the Position of a Retrovirus Packaging Sequence Results in
JOURNAL OF VIROLOGY, May 1985, p. 401-407 0022-538X/85/050401-07$02.00/0 Copyright C 1985, American Society for Microbiology Vol. 54, No. 2 Varying the Position of a Retrovirus Packaging Sequence Results
More informationJumpstart your research with ViraPower Lentiviral Expression Systems
ViraPower Lentiviral Expression Systems Jumpstart your research with ViraPower Lentiviral Expression Systems With ViraPower Lentiviral Systems you can: Efficiently transduce both dividing and non-dividing
More informationSequences in the 5 and 3 R Elements of Human Immunodeficiency Virus Type 1 Critical for Efficient Reverse Transcription
JOURNAL OF VIROLOGY, Sept. 2000, p. 8324 8334 Vol. 74, No. 18 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Sequences in the 5 and 3 R Elements of Human
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationCenters for Disease Control August 9, 2004
HIV CDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm
More informationNOTES. sequences were inserted into a puc19-derived plasmid backbone,
JOURNAL OF VIROLOGY, Sept. 1994, p. 6047-6051 0022-538X/94/$04.00+0 Copyright 1994, American Society for Microbiology Vol. 68, No. 9 NOTES A Human Immunodeficiency Virus Type 1 (HIV-1)-Based Retroviral
More informationMedChem 401~ Retroviridae. Retroviridae
MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The
More informationon August 19, 2018 by guest
JOURNAL OF VIROLOGY, Nov. 1999, p. 9589 9598 Vol. 73, No. 11 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. A Lentivirus Packaging System Based on Alternative
More informationChoosing Optimal Viral Vector for T-cell Transduction. Viral vectors for blood cells
Choosing Optimal Viral Vector for T-cell Transduction Max Mamonkin, PhD Center for Cell and Gene Therapy Baylor College of Medicine PACT Webinar Nov 08, 2018 Viral for blood cells Short/long term gene
More informationNC Pol RNA RNA DNA D C T RNA. retroviruses/ Gag Pol Env. E/psi. E/psi RNA. MA CA NC MA Env CA 2-4
55 pp.153 160 2005 RN 1. 100nm RN D T http://www.ncbi.nlm.nih.gov/ retroviruses/ ag Pol Env ag 4 6 M N M Env 565-0871 3-1 TEL 06-6879-8348 FX 06-6879-8347 E-mail sakuragi@biken.osaka-u.ac.jp N Pol PR RT
More informationSECTION 25-1 REVIEW STRUCTURE. 1. The diameter of viruses ranges from about a. 1 to 2 nm. b. 20 to 250 nm. c. 1 to 2 µm. d. 20 to 250 µm.
SECTION 25-1 REVIEW STRUCTURE VOCABULARY REVIEW Define the following terms. 1. virus 2. capsid 3. retrovirus 4. viroid 5. prion MULTIPLE CHOICE Write the correct letter in the blank. 1. The diameter of
More informationCurrent Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a Case Study
Note: I have added some clarifying comments to the slides -- please click on Comments under View to see them. Current Strategies in HIV-1 Vaccine Development Using Replication-Defective Adenovirus as a
More informationHuman Immunodeficiency Virus
Human Immunodeficiency Virus Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Viruses and hosts Lentivirus from Latin lentis (slow), for slow progression of disease
More informationPrimate and Feline Lentivirus Vector RNA Packaging and Propagation by Heterologous Lentivirus Virions
JOURNAL OF VIROLOGY, June 2001, p. 5129 5140 Vol. 75, No. 11 0022-538X/01/$04.00 0 DOI: 10.1128/JVI.75.11.5129 5140.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved. Primate
More informationHIV & AIDS: Overview
HIV & AIDS: Overview UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR VJ TEMPLE 1 What
More informationDownloaded from UvA-DARE, the institutional repository of the University of Amsterdam (UvA)
Downloaded from UvA-DARE, the institutional repository of the University of Amsterdam (UvA) http://hdl.handle.net/11245/2.2816 File ID Filename Version uvapub:2816 26745y.pdf unknown SOURCE (OR PART OF
More informationFig. 1: Schematic diagram of basic structure of HIV
UNIVERSITY OF PAPUA NEW GUINEA SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY PBL SEMINAR HIV & AIDS: An Overview What is HIV?
More informationClinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2007, p. 550 578 Vol. 20, No. 4 0893-8512/07/$08.00 0 doi:10.1128/cmr.00017-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. Clinical Significance
More informationof an Infectious Form of Rous Sarcoma Virus*
Proceedings of the National Academy of Sciences Vol. 66, No. 2, pp. 314-321, June 1970 A Cell-Associated Factor Essential for Formation of an Infectious Form of Rous Sarcoma Virus* H. Hanafusa, T. Miyamoto,
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationExpression of Foreign Genest
JOURNAL OF VIROLOGY, May 1992, p. 2731-2739 0022-538X/92/052731-09$02.00/0 Copyright 1992, American Society for Microbiology Vol. 66, No. 5 Human Immunodeficiency Virus Vectors for Inducible Expression
More informationScreening for Complex Phenotypes
Screening for Complex Phenotypes Michael Hemann hemann@mit.edu Screening for cancer phenotypes in mice How do we typically model cancer in mice? Tumor Suppressor KO Oncogene transgenesis Problems with
More informationRegulated Lentiviral Packaging Cell Line Devoid of Most Viral cis-acting Sequences
VIROLOGY 249, 167 174 (1998) ARTICLE NO. VY989327 Regulated Lentiviral Packaging Cell Line Devoid of Most Viral cis-acting Sequences Malvika Kaul,*, Hong Yu,*,1 Yacov Ron,* and Joseph P. Dougherty*,2 *Department
More informationThe Bovine Leukemia Virus Encapsidation Signal Is Composed of RNA Secondary Structures
JOURNAL OF VIROLOGY, Apr. 1998, p. 3196 3204 Vol. 72, No. 4 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology The Bovine Leukemia Virus Encapsidation Signal Is Composed of RNA Secondary
More informationCharged Amino Acid Residues of Human Immunodeficiency Virus Type 1 Nucleocapsid p7 Protein Involved in RNA Packaging and Infectivity
JOURNAL OF VIROLOGY, Oct. 1996, p. 6607 6616 Vol. 70, No. 10 0022-538X/96/$04.00 0 Copyright 1996, American Society for Microbiology Charged Amino Acid Residues of Human Immunodeficiency Virus Type 1 Nucleocapsid
More informationSubgenomic mrna. and is associated with a replication-competent helper virus. the trans-acting factors necessary for replication of Rev-T.
JOURNAL OF VIROLOGY, Apr. 1986, p. 75-80 0022-538X/86/040075-06$02.00/0 Copyright C) 1986, American Society for Microbiology Vol. 58, No. 1 Insertion of Several Different DNAs in Reticuloendotheliosis
More informationmutants has revealed at least three sites that are involved in
JOURNAL OF VIROLOGY, Jan. 1989, p. 319-327 0022-538X89010319-09$02.000 Copyright 1989, American Society for Microbiology Vol. 63, No. 1 Construction and Analysis of Deletion Mutations in the U5 Region
More informationEffects of 3 Untranslated Region Mutations on Plus-Strand Priming during Moloney Murine Leukemia Virus Replication
JOURNAL OF VIROLOGY, Feb. 1999, p. 948 957 Vol. 73, No. 2 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Effects of 3 Untranslated Region Mutations on Plus-Strand
More informationReverse transcription and integration
Reverse transcription and integration Lecture 9 Biology 3310/4310 Virology Spring 2018 One can t believe impossible things, said Alice. I dare say you haven t had much practice, said the Queen. Why, sometimes
More informationVIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer
VIRAL TITER COUNTS The best methods of measuring infectious lentiviral titer FLUORESCENCE CYCLES qpcr of Viral RNA SUMMARY Viral vectors are now routinely used for gene transduction in a wide variety of
More informationIII. What are the requirements for taking and passing this course?
1 Molecular Virology Lecture # 1: Course Introduction I. Instructor and Background Dr. Richard Kuhn rjkuhn@bragg.bio.purdue.edu B-129 Lilly Hall 494-1164 Office Hours - Wednesday 10:30-11:30 II. Objective:
More informationSection 6. Junaid Malek, M.D.
Section 6 Junaid Malek, M.D. The Golgi and gp160 gp160 transported from ER to the Golgi in coated vesicles These coated vesicles fuse to the cis portion of the Golgi and deposit their cargo in the cisternae
More informationCHEN LIANG, 1 LIWEI RONG, 1 YUDONG QUAN, 1 MICHAEL LAUGHREA, 1 LAWRENCE KLEIMAN, 1,2
JOURNAL OF VIROLOGY, Aug. 1999, p. 7014 7020 Vol. 73, No. 8 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Mutations within Four Distinct Gag Proteins Are
More informationJulianne Edwards. Retroviruses. Spring 2010
Retroviruses Spring 2010 A retrovirus can simply be referred to as an infectious particle which replicates backwards even though there are many different types of retroviruses. More specifically, a retrovirus
More informationSimian Immunodeficiency Virus RNA Is Efficiently Encapsidated by Human Immunodeficiency Virus Type 1 Particles
JOURNAL OF VIROLOY, May 1993, p. 2681-2688 0022-538X/93/052681-08$02.00/0 Copyright 3 1993, American Society for Microbiology Vol. 67, No. 5 Simian Immunodeficiency Virus RNA Is Efficiently Encapsidated
More informationA Safe Packaging Line for Gene Transfer: Separating Viral Genes on Two Different Plasmids
JOURNAL OF VIROLOGY, Apr. 1988, p. 1120-1124 0022-538X/88/041120-05$02.00/0 Copyright C 1988, American Society for Microbiology Vol. 62, No. 4 A Safe Packaging Line for Gene Transfer: Separating Viral
More informationReceived 19 May 2004/Accepted 13 September 2004
JOURNAL OF VIROLOGY, Feb. 2005, p. 1666 1677 Vol. 79, No. 3 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.3.1666 1677.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Genetic Recombination
More informationLESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication
DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit
More informationToward the Safe Use of Lentivirus and Retrovirus Vector Systems
27 July, 2017 The Asian Conference on Safety & Education in Laboratory Toward the Safe Use of Lentivirus and Retrovirus Vector Systems Takaomi Sanda, MD, PhD Principal Investigator, Cancer Science Institute
More informationU1snRNP-mediated suppression of polyadenylation in conjunction with the RNA structure controls poly (A) site selection in foamy viruses
Retrovirology This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. U1snRNP-mediated suppression
More information7.012 Problem Set 6 Solutions
Name Section 7.012 Problem Set 6 Solutions Question 1 The viral family Orthomyxoviridae contains the influenza A, B and C viruses. These viruses have a (-)ss RNA genome surrounded by a capsid composed
More informationTranscription and RNA processing
Transcription and RNA processing Lecture 7 Biology W3310/4310 Virology Spring 2016 It is possible that Nature invented DNA for the purpose of achieving regulation at the transcriptional rather than at
More informationPoly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal p~lyaden~lation
Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal p~lyaden~lation d A by thddownstreim major splice donor site Mark P. Ashe, Philip Griffin, William James, and Nick J. Proudfoot
More informationHepadnaviruses: Variations on the Retrovirus Theme
WBV21 6/27/03 11:34 PM Page 377 Hepadnaviruses: Variations on the Retrovirus Theme 21 CHAPTER The virion and the viral genome The viral replication cycle The pathogenesis of hepatitis B virus A plant hepadnavirus
More informationViral vectors. Part I. 27th October 2014
Viral vectors Part I 27th October 2014 Prof. Józef Dulak, PhD, DSc Department of Medical Biotechnology Faculty of Biochemistry, Biophysics and Biotechnology Room 3.025/3.07 Phone 664-63-75 Email: jozef.dulak@uj.edu.pl
More informationReceived 15 October 1997/Accepted 17 February 1998
JOURNAL OF VIROLOGY, June 1998, p. 4765 4774 Vol. 72, No. 6 0022-538X/98/$04.00 0 Copyright 1998, American Society for Microbiology Mutations in the Leucine Zipper-Like Heptad Repeat Sequence of Human
More informationGenetic Dissociation of the Encapsidation and Reverse Transcription Functions in the 5 R Region of Human Immunodeficiency Virus Type 1
JOURNAL OF VIROLOGY, Jan. 1999, p. 101 109 Vol. 73, No. 1 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Genetic Dissociation of the Encapsidation and Reverse
More informationCRISPRaTest Functional dcas9-activator Assay Kit v1 Last update: 2018/07/04 Cellecta, Inc.
CRISPRaTest Functional dcas9-activator Assay Kit v1 Last update: 2018/07/04 Cellecta, Inc. Copyright (c) 2018 Cellecta, Inc. All Rights Reserved. Table of Contents 1. CRISPRaTest Functional dcas9-activator
More informationTranscription and RNA processing
Transcription and RNA processing Lecture 7 Biology 3310/4310 Virology Spring 2018 It is possible that Nature invented DNA for the purpose of achieving regulation at the transcriptional rather than at the
More informationInhibition of trna 3 Lys -Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency Virus Type 1 Replication
JOURNAL OF VIROLOGY, Dec. 2006, p. 11710 11722 Vol. 80, No. 23 0022-538X/06/$08.00 0 doi:10.1128/jvi.01038-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Inhibition of trna
More information19 Viruses BIOLOGY. Outline. Structural Features and Characteristics. The Good the Bad and the Ugly. Structural Features and Characteristics
9 Viruses CAMPBELL BIOLOGY TENTH EDITION Reece Urry Cain Wasserman Minorsky Jackson Outline I. Viruses A. Structure of viruses B. Common Characteristics of Viruses C. Viral replication D. HIV Lecture Presentation
More informationReverse Genetics of RNA Viruses
Reverse Genetics of RNA Viruses Reverse Genetics (RG) he creation of a virus with a fulllength copy of the viral genome he most powerful tool in modern virology RG of RNA viruses Generation or recovery
More informationUtilization of Nonviral Sequences for Minus-Strand DNA Transfer and Gene Reconstitution during Retroviral Replication
JOURNAL OF VIROLOGY, Oct. 2000, p. 9571 9579 Vol. 74, No. 20 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Utilization of Nonviral Sequences for Minus-Strand
More informationCDC site UNAIDS Aids Knowledge Base http://www.cdc.gov/hiv/dhap.htm http://hivinsite.ucsf.edu/insite.jsp?page=kb National Institute of Allergy and Infectious Diseases http://www.niaid.nih.gov/default.htm
More informationReceived 19 February 2002/Accepted 4 May 2002
JOURNAL OF VIROLOGY, Sept. 2002, p. 9096 9102 Vol. 76, No. 18 0022-538X/02/$04.00 0 DOI: 10.1128/JVI.76.18.9096 9102.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved. Effect
More informationViral Genetics. BIT 220 Chapter 16
Viral Genetics BIT 220 Chapter 16 Details of the Virus Classified According to a. DNA or RNA b. Enveloped or Non-Enveloped c. Single-stranded or double-stranded Viruses contain only a few genes Reverse
More informationReceived 7 September 1988/Accepted 11 November 1988
JOURNAL OF VIROLOGY, Mar. 1989, p. 1455-1459 0022-538X/89/031455-05$02.00/0 Copyright C) 1989, American Society for Microbiology Vol. 63, No. 3 Genetic Recombination of Human Immunodeficiency Virus FRANQOIS
More informationB19, see Parvovirus B19 Bone marrow, gene transfer with parvovirus. Erythrovirus, see Parvovirus B19, Simian parvovirus
... Subject Index Adeno-associated virus Cap and genome encapsidation 87 DNA integration homologous recombination 90, 91 latency vs replication 77, 78 mechanism 79 requirements 78, 79 site in human genome
More informationReplication of Lengthened Moloney Murine Leukemia Virus Genomes Is Impaired at Multiple Stages
JOURNAL OF VIROLOGY, Mar. 2000, p. 2694 2702 Vol. 74, No. 6 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Replication of Lengthened Moloney Murine Leukemia
More informationSUPPLEMENTARY INFORMATION
sirna pool: Control Tetherin -HA-GFP HA-Tetherin -Tubulin Supplementary Figure S1. Knockdown of HA-tagged tetherin expression by tetherin specific sirnas. HeLa cells were cotransfected with plasmids expressing
More informationHigh Rate of Genetic Rearrangement during Replication of a Moloney Murine Leukemia Virus-Based Vector
JOURNAL OF VIROLOGY, Nov. 1993, p. 6357-6364 0022-538X/93/1 16357-08$02.00/0 Copyright 1993, American Society for Microbiology Vol. 67, No. 11 High Rate of Genetic Rearrangement during Replication of a
More informationOverview: Chapter 19 Viruses: A Borrowed Life
Overview: Chapter 19 Viruses: A Borrowed Life Viruses called bacteriophages can infect and set in motion a genetic takeover of bacteria, such as Escherichia coli Viruses lead a kind of borrowed life between
More informationHigh level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector
Gene Therapy (1998) 5, 1665 1676 1998 Stockton Press All rights reserved 0969-7128/98 $12.00 http://www.stockton-press.co.uk/gt High level inhibition of HIV replication with combination RNA decoys expressed
More informationSilent Point Mutation in an Avian Retrovirus RNA Processing Element Promotes c-myb-associated Short-Latency Lymphomas
JOURNAL OF VIROLOGY, Sept. 2003, p. 9378 9387 Vol. 77, No. 17 0022-538X/03/$08.00 0 DOI: 10.1128/JVI.77.17.9378 9387.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Silent
More informationL I F E S C I E N C E S
1a L I F E S C I E N C E S 5 -UUA AUA UUC GAA AGC UGC AUC GAA AAC UGU GAA UCA-3 5 -TTA ATA TTC GAA AGC TGC ATC GAA AAC TGT GAA TCA-3 3 -AAT TAT AAG CTT TCG ACG TAG CTT TTG ACA CTT AGT-5 OCTOBER 31, 2006
More informationProkaryotic Biology. VIRAL STDs, HIV-1 AND AIDS
Prokaryotic Biology VIRAL STDs, HIV-1 AND AIDS Prokaryotic Biology FROM THE CDC VIRAL STDs, HIV-1 AND AIDS VIRAL STDs & CONTACT VIRAL DISEASES A. GENITAL HERPES & COLD SORES 1. HERPES SIMPLEX VIRUS-2 (HHV-2)
More informationMutant Human Immunodeficiency Virus Type 1 Genomes with Defects in RNA Dimerization or Encapsidation
JOURNAL OF VIROLOGY, May 1997, p. 3407 3414 Vol. 71, No. 5 0022-538X/97/$04.00 0 Copyright 1997, American Society for Microbiology Mutant Human Immunodeficiency Virus Type 1 Genomes with Defects in RNA
More informationA Stable System for the High-Titer Production of Multiply Attenuated Lentiviral Vectors
doi:10.1006/mthe.2000.0103, available online at http://www.idealibrary.com on IDEAL A Stable System for the High-Titer Production of Multiply Attenuated Lentiviral Vectors Natacha Klages, Romain Zufferey,
More informationTranscription Termination and Polyadenylation
MICROBIOLOGICAL REVIEWS, Sept. 1993, p. 511-521 0146-0749/93/030511-11$02.00/0 Copyright X 1993, American Society for Microbiology Vol. 57, No. 3 Transcription Termination and Polyadenylation in Retroviruses
More informationComplementation of Human Immunodeficiency Virus Type 1 Replication by Intracellular Selection of Escherichia coli trna 3 Lys Supplied in trans
JOURNAL OF VIROLOGY, Oct. 2006, p. 9641 9650 Vol. 80, No. 19 0022-538X/06/$08.00 0 doi:10.1128/jvi.00709-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Complementation of Human
More information